EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS

Aim. To evaluate an antihypertensive efficacy and influence on the arterial stiffness of 24-week treatment with metoprolol tartrate in patients with hypertension (HT) degree 1-2. Material and Methods. Patients with HT degree 1-2 (n=38) received therapy with metoprolol tartrate 50-200 mg QD for 24 we...

Full description

Saved in:
Bibliographic Details
Main Authors: V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/956
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227818971430912
author V. E. Oleynikov
I. B. Matrosova
Y. A. Tomashevskaya
L. I. Gusakovskaya
E. A. Melnikova
author_facet V. E. Oleynikov
I. B. Matrosova
Y. A. Tomashevskaya
L. I. Gusakovskaya
E. A. Melnikova
author_sort V. E. Oleynikov
collection DOAJ
description Aim. To evaluate an antihypertensive efficacy and influence on the arterial stiffness of 24-week treatment with metoprolol tartrate in patients with hypertension (HT) degree 1-2. Material and Methods. Patients with HT degree 1-2 (n=38) received therapy with metoprolol tartrate 50-200 mg QD for 24 weeks. Bifunctional daily blood pressure (BP) and electrocardiogramm monitoring with evaluation of central aortic pressure indicators as well as volume sphygmography were performed at baseline and after 24 weeks of therapy. Results. The 24-week  therapy with metoprolol  tartrate was effective  in 47.2% of patients. Significant  improvement  in central aortic pressure  [systolic BP decreased  from 129.8±7.3  to 118.8±7.2 mm Hg; p<0.001; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p<0.001] with the not significant changes of augmentation index (from 18.3±13.2 to 19.5±13.4; p>0.05). Significant reduction in arterial stiffness indexes was revealed with volume sphygmography: CAVI1 from 8.6 (8.1;9.6) to 8.0 (7.3;8.3); p<0.01; L-CAVI1 from 8.9 (7.6;9.9) to 7.9 (7.2;8.5), p<0.001. Conclusion. Metoprolol tartrate is an effective antihypertensive drug that improves the structural and functional properties of arteries.
format Article
id doaj-art-c1002c117fea47d4a38587138a9b82cc
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2016-01-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-c1002c117fea47d4a38587138a9b82cc2025-08-23T10:00:24ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-017668568910.20996/1819-6446-2011-7-6-685-689955EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESSV. E. Oleynikov0I. B. Matrosova1Y. A. Tomashevskaya2L. I. Gusakovskaya3E. A. Melnikova4Penza State University , Institute of MedicinePenza State University , Institute of MedicinePenza State University , Institute of MedicinePenza State University , Institute of MedicinePenza State University , Institute of MedicineAim. To evaluate an antihypertensive efficacy and influence on the arterial stiffness of 24-week treatment with metoprolol tartrate in patients with hypertension (HT) degree 1-2. Material and Methods. Patients with HT degree 1-2 (n=38) received therapy with metoprolol tartrate 50-200 mg QD for 24 weeks. Bifunctional daily blood pressure (BP) and electrocardiogramm monitoring with evaluation of central aortic pressure indicators as well as volume sphygmography were performed at baseline and after 24 weeks of therapy. Results. The 24-week  therapy with metoprolol  tartrate was effective  in 47.2% of patients. Significant  improvement  in central aortic pressure  [systolic BP decreased  from 129.8±7.3  to 118.8±7.2 mm Hg; p<0.001; dyastolic BP decreased from 90 (87;93) to 80 (77;84) mm Hg; p<0.001] with the not significant changes of augmentation index (from 18.3±13.2 to 19.5±13.4; p>0.05). Significant reduction in arterial stiffness indexes was revealed with volume sphygmography: CAVI1 from 8.6 (8.1;9.6) to 8.0 (7.3;8.3); p<0.01; L-CAVI1 from 8.9 (7.6;9.9) to 7.9 (7.2;8.5), p<0.001. Conclusion. Metoprolol tartrate is an effective antihypertensive drug that improves the structural and functional properties of arteries.https://www.rpcardio.online/jour/article/view/956arterial hypertensionbeta-blockerscentral aortic pressurepulse wave velocityaugmentation indexmetoprolol tartrate
spellingShingle V. E. Oleynikov
I. B. Matrosova
Y. A. Tomashevskaya
L. I. Gusakovskaya
E. A. Melnikova
EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
Рациональная фармакотерапия в кардиологии
arterial hypertension
beta-blockers
central aortic pressure
pulse wave velocity
augmentation index
metoprolol tartrate
title EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
title_full EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
title_fullStr EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
title_full_unstemmed EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
title_short EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
title_sort effect of metoprolol therapy on the arterial stiffness
topic arterial hypertension
beta-blockers
central aortic pressure
pulse wave velocity
augmentation index
metoprolol tartrate
url https://www.rpcardio.online/jour/article/view/956
work_keys_str_mv AT veoleynikov effectofmetoprololtherapyonthearterialstiffness
AT ibmatrosova effectofmetoprololtherapyonthearterialstiffness
AT yatomashevskaya effectofmetoprololtherapyonthearterialstiffness
AT ligusakovskaya effectofmetoprololtherapyonthearterialstiffness
AT eamelnikova effectofmetoprololtherapyonthearterialstiffness